Insilico Medicine nominates ISM9546, an oral VAV1 degrader designed with generative AI, as a preclinical candidate for ...
Multi-omics study reveals how myeloid-derived IL6/JAK/STAT3 signaling creates a spatially organized immunosuppressive niche ...
A formulation combining a plant-derived Lactobacillus plantarum strain with a human-derived Lactobacillus fermentum strain ...
Week 12 clinical remission of 23.1% (3/13) in higher-dose Cohort 2 vs. 11.4% (4/35) in lower-dose Cohort 138.9% ...
The therapeutic options for patients with inflammatory bowel disease (IBD) have recently expanded substantially. Tofacitinib, ...
MedPage Today on MSN
Multiple sclerosis anti-CD20 drug linked to bowel disease risk
IBD risk was higher with rituximab versus other MS drugs, but cumulative incidence was low ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Commission (EC) has approved KEYTRUDA ® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination ...
Building on Omvoh's approved use and durable efficacy in adults, Lilly plans to submit these data to global regulators to support a potential label ...
A North Port woman says she was bitten by mosquitoes near home before contracting dengue. Her case was reported, but Sarasota ...
Researchers found that gut-derived GLP-1 and GLP-2 signaling helped protect mice against T cell-induced intestinal injury, with GLP-1R primarily regulating inflammation and GLP-2R supporting ...
The discrepancy raises questions about how the Department of Health determines where infections originate and whether the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results